Cue biopharma to participate in fireside chat at the citizens life sciences conference

Boston, may 05, 2025 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific t cells for the treatment of autoimmune disease and cancer, today announced that it will participate in a fireside chat at the citizens life sciences conference being held in new york, may 7-8, 2025.
CUE Ratings Summary
CUE Quant Ranking